EXCLUSIVE: TrumpRx Wins Praise From Rep. Tim Moore as Republicans Highlight Lower Drug Costs
President Donald Trump’s “TrumpRx” drug pricing initiative is continuing to draw praise from Republicans who say the policy is helping lower healthcare costs for working families.
Rep. Tim Moore (R. N.C.) told the Washington Reporter that voters in his district are responding positively to the Administration’s effort to reduce prescription drug prices.
“What I’ve heard so far has been positive about providing better ways that consumers can afford their medications,” Moore said. “I’m open to all sorts of ideas, and I am just proud that this president has taken it seriously.”
The comments come as Republicans increasingly point to TrumpRx as one of the Administration’s most significant affordability policies. The initiative has drawn attention for efforts to lower the cost of certain prescription drugs by as much as 80 percent.
The Reporter has previously covered how lawmakers and outside groups have praised the Administration’s focus on lowering healthcare costs through the program. Earlier reporting highlighted support from conservatives who argued that lower prescription drug costs are a direct economic issue for seniors and working families already dealing with inflation and higher living expenses.
The issue has also become politically important in swing districts where healthcare affordability remains a top concern for voters. Republicans have increasingly argued that lowering drug prices fits within a broader economic message centered on reducing costs for consumers.
Moore’s comments reflect how many Republicans are approaching the issue. Rather than criticizing government efforts to address pricing concerns outright, lawmakers are emphasizing policies they believe increase affordability while maintaining market competition and encouraging innovation.
The Trump Administration has made healthcare affordability a major part of its economic message during the second term, with drug pricing reform serving as one of the centerpiece issues. Republicans on Capitol Hill have also pointed to the policy as evidence that the Administration is focused on kitchen-table economic concerns instead of the regulatory and spending priorities pushed by Democrats.
